Safety and effectiveness of mirabegron in patients ≥75 yrs with overactive bladder: analysis of a Japanese post-marketing commitment study

Yoshida M1, Nozawa Y2, Kato D2, Tabuchi H2, Kuroishi K2

Research Type

Clinical

Abstract Category

Overactive Bladder

Abstract 640
Open Discussion ePosters 3
Scientific Open Discussion Session 35
Friday 15th September 2017
13:35 - 13:40 (ePoster Station 6)
Exhibition Hall
Overactive Bladder Gerontology Quality of Life (QoL) Questionnaire
1. Department of Urology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan, 2. Astellas Pharma Inc, Tokyo, Japan
Presenter
M

Masaki Yoshida
Department of Urology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan

Links

Poster

Abstract

04/02/2026 14:00:26